期刊文献+

MMP-2、PTEN在骨肉瘤组织中的表达及临床意义 被引量:7

EXPRESSION OF MMP-2 AND PTEN IN OSTEOSARCOMA
下载PDF
导出
摘要 目的探讨基质金属蛋白酶-2(MMP-2)及张力蛋白和辅助蛋白同源、第10号染色体丢失的磷酸酶(PTEN)的表达在骨肉瘤发生、发展中的作用及其相互关系。方法应用免疫组化SP法检测40例骨肉瘤组织、20例骨软骨瘤组织中MMP-2、PTEN蛋白的表达情况,并分析两者之间表达的相关性。结果MMP-2在骨肉瘤组织中的阳性率为65%(26/40),而在骨软骨瘤组织中的阳性率为0,差异具有显著性(χ2=7.253,P<0.01)。PTEN蛋白在骨肉瘤组织中的阳性表达率为55%(22/40),而在骨软骨瘤组织中为90%(18/20),两者相比差异有统计学意义(χ2=4.164,P<0.05)。在骨肉瘤组织中,MMP-2和PTEN表达强度之间呈负相关(r=-0.403,P<0.05)。结论MMP-2和PTEN与骨肉瘤的发生、发展以及侵袭、转移有关,且两者具有相关性,联合检测MMP-2和PTEN的表达将对骨肉瘤的早期诊断、预后判断有一定指导意义。 Objective To study the expression of matrix mental protein (MMP-2) and (PTEN) in osteosareoma and their clinical significance as well as their correlation Methods Immunohistochemistry (S-P method) was applied to study the expressions of MMP-2 and PTEN in tissues of osteosarcoma (n 40) and osteochondroma (n=20). Results Expression of MMP-2 was positive in 65% of osteosarcoma (26/40) and negative in osteochondroma, while expression of PTEN was found positive in 55% of osteosarcoma (22/40) and 90% in osteochondroma (18/20). The difference between them was significant (χ^2=4. 164,P〈 0.05). Negative correlation was observed between the expression of MMP 2 and PTEN in osteosarcoma (r =-0. 403,P〈0.05). Conclusion MMP-2 and PTEN may be related to the carcinogensis and metastasis of osteosarcoma. Detection of MMP-2 and PTEN expression is of certain significance in early diagnosis and assessment of its prognosis.
出处 《青岛大学医学院学报》 CAS 2007年第6期500-502,共3页 Acta Academiae Medicinae Qingdao Universitatis
关键词 骨肉瘤 明胶酶A PTEN 免疫组织化学 osteosarcoma gelatinase A PTEN immunohistochemistry
  • 相关文献

参考文献4

二级参考文献9

  • 1Steck PA, Pershouse MA, Jasser SA, et al. Identification of a candidate tumor suppressor gene, MMACI, at chromosome 10q23. 3 that is mutated in multiple advanced cancers[J]. Nat Genet, 1997,15(4) :356.
  • 2Li J, Yen C, Liaw D, et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer[J]. Science, 1997,275(5308):1943.
  • 3Risinger JI, Hayes AK, Berchuck A, et al. PTEN/MMAC1 mutations in endometrial cancers[J]. Cancer Res, 1997, 57:4736.
  • 4Tashiro H, Blazes MS, Wu R, et ak Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies[J]. Cancer Res, 1997,57 : 3935.
  • 5Kim SK, Ro JY, Kemp BL, et al. Identification of two distinct tumor suppressor loci on the lung arm of chromosome 10 in small cell lung cancer[J]. Oncogene, 1998,17 : 1749.
  • 6Kohno T, Takahashi M, Manda R, et al. Inactivation of the PTEN/MMAC1/TEP1 gene in human man lung cancers[J].Genes Chromosomes Cancer, 1998,22 : 152.
  • 7Sano T, Lin H, Chen X,et al. Differential expression of MMACI/PTEN in glioblastoma multiforme: relationship to localization and prognosis[J]. Cancer Res, 1999,59 (8) : 1820.
  • 8Mcmenamin ME, Soung P, Perera S, et al. Loss of PTEN expression in paraffinembedded primary prostate cancer correlates with high gleason score and advanced stage[J]. Cancer Res, 1999, 59: 4291.
  • 9Bian J H,Mol Cell Biol,1997年,17卷,11期,6330页

共引文献39

同被引文献104

引证文献7

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部